Drug Shortage Report for TEVA-NYSTATIN
| Report ID | 218955 |
| Drug Identification Number | 02194201 |
| Brand name | TEVA-NYSTATIN |
| Common or Proper name | TEVA-NYSTATIN 100MU/ML DROPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NYSTATIN |
| Strength(s) | 100000UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 1L |
| ATC code | A07AA |
| ATC description | INTESTINALANTIINFECTIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-07 |
| Estimated end date | 2025-03-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-13 |
| Company comments | Under Allocations |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-02-08 | English | Compare |
| v2 | 2024-02-08 | French | Compare |
| v3 | 2024-02-22 | English | Compare |
| v4 | 2024-02-22 | French | Compare |
| v5 | 2024-03-07 | English | Compare |
| v6 | 2024-03-07 | French | Compare |
| v7 | 2024-06-20 | English | Compare |
| v8 | 2024-06-20 | French | Compare |
| v9 | 2024-06-27 | English | Compare |
| v10 | 2024-06-27 | French | Compare |
| v11 | 2024-09-19 | English | Compare |
| v12 | 2024-09-19 | French | Compare |
| v13 | 2024-10-07 | English | Compare |
| v14 | 2024-10-07 | French | Compare |
| v15 | 2024-10-11 | English | Compare |
| v16 | 2024-10-11 | English | Compare |
| v17 | 2024-10-11 | French | Compare |
| v18 | 2024-10-24 | English | Compare |
| v19 | 2024-10-24 | French | Compare |
| v20 | 2024-11-08 | English | Compare |